WallStreetZenWallStreetZen

NASDAQ: FHTX
Foghorn Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Foghorn Therapeutics earnings were -$64.6M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest FHTX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$7.2M, down 63.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FHTX reported annual earnings of -$74.3M, with -14.2% growth. The next FHTX earnings date is Nov 4, 2026.

FHTX earnings history

Current Revenue
$36.7M
Current Earnings
-$64.6M
Current Profit Margin
-175.8%

FHTX Return on Equity

Insufficient data to display

FHTX Return on Assets

Current Company
-31.2%
Current Industry
-10.3%
FHTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when FHTX announces earnings.

FHTX Return on Capital Employed

Current Company
-42.26%
Current Industry
-7%
FHTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FHTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
FHTX-$60.12M-$64.58MN/A-$0.98
RNAC-$156.74M-$153.94MN/A-$5.94
WHWK-$79.82M-$79.83MN/A-$1.15
AKBA-$10.04M-$29.67MN/A-$0.11
STRO-$169.19M-$180.64MN/A-$17.36
View Top Biotech Stocks

FHTX earnings dates

Next earnings date
Nov 4, 2026

Foghorn Therapeutics Earnings Reports & History FAQ

What were Foghorn Therapeutics's earnings last quarter?

On FHTX's earnings call on Aug 4, 2026, Foghorn Therapeutics (NASDAQ: FHTX) reported Q2 2026 earnings per share (EPS) of -$0.10, up 64.29% year over year. Total FHTX earnings for the quarter were -$7.19 million. In the same quarter last year, Foghorn Therapeutics's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Foghorn Therapeutics stock.

When does Foghorn Therapeutics report earnings?

The next FHTX earnings date is Nov 4, 2026. Add FHTX to your watchlist to be reminded of Foghorn Therapeutics's next earnings date.

Is Foghorn Therapeutics profitable or losing money?

As of the last Foghorn Therapeutics earnings report, Foghorn Therapeutics is currently losing money. Foghorn Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$64.58 million, a 14.35% decrease year over year.

What was FHTX's earnings growth in the past year?

As of Foghorn Therapeutics's earnings date in Aug 4, 2026, Foghorn Therapeutics's earnings has grown year over year. FHTX earnings in the past year totalled -$64.58 million.

What are Foghorn Therapeutics's earnings expectations?

The current EPS estimate for Foghorn Therapeutics's earnings report in Nov 4, 2026 is -$0.22.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.